243 related articles for article (PubMed ID: 27913630)
1. Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
Redondo-Pachón D; Crespo M; Yélamos J; Muntasell A; Pérez-Sáez MJ; Pérez-Fernández S; Vila J; Vilches C; Pascual J; López-Botet M
J Immunol; 2017 Jan; 198(1):94-101. PubMed ID: 27913630
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Evolution of the Adaptive NKG2C
Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Alari-Pahissa E; Pérez-Sáez MJ; Altadill M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
J Immunol; 2021 Oct; 207(7):1882-1890. PubMed ID: 34470855
[TBL] [Abstract][Full Text] [Related]
3. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
[TBL] [Abstract][Full Text] [Related]
4. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.
Calabrese DR; Chong T; Wang A; Singer JP; Gottschall M; Hays SR; Golden JA; Kukreja J; Lanier LL; Tang Q; Greenland JR
Transplantation; 2019 Mar; 103(3):493-501. PubMed ID: 30211828
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.
Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P
Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients.
Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Heredia G; Pérez-Sáez MJ; Vila J; Costa-García M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
Am J Transplant; 2020 Mar; 20(3):663-676. PubMed ID: 31612635
[TBL] [Abstract][Full Text] [Related]
7. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
Muñoz-Cobo B; Giménez E; Solano C; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Navarro D
J Med Virol; 2014 May; 86(5):806-11. PubMed ID: 24105728
[TBL] [Abstract][Full Text] [Related]
9. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.
Harpur CM; Stankovic S; Kanagarajah A; Widjaja JML; Levvey BJ; Cristiano Y; Snell GI; Brooks AG; Westall GP; Sullivan LC
Transplantation; 2019 Aug; 103(8):1689-1699. PubMed ID: 30461721
[TBL] [Abstract][Full Text] [Related]
10. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.
Ishiyama K; Arakawa-Hoyt J; Aguilar OA; Damm I; Towfighi P; Sigdel T; Tamaki S; Babdor J; Spitzer MH; Reed EF; Sarwal MM; Lanier LL;
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35181606
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
12. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
Muntasell A; Vilches C; Angulo A; López-Botet M
Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990
[TBL] [Abstract][Full Text] [Related]
13. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
[TBL] [Abstract][Full Text] [Related]
14. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
Muntasell A; López-Montañés M; Vera A; Heredia G; Romo N; Peñafiel J; Moraru M; Vila J; Vilches C; López-Botet M
Eur J Immunol; 2013 Dec; 43(12):3268-78. PubMed ID: 24030638
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on NKG2C and the human NK-cell response to CMV infection.
Malmberg KJ; Beziat V; Ljunggren HG
Eur J Immunol; 2012 Dec; 42(12):3141-5. PubMed ID: 23255011
[TBL] [Abstract][Full Text] [Related]
16. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children.
Noyola DE; Fortuny C; Muntasell A; Noguera-Julian A; Muñoz-Almagro C; Alarcón A; Juncosa T; Moraru M; Vilches C; López-Botet M
Eur J Immunol; 2012 Dec; 42(12):3256-66. PubMed ID: 22965785
[TBL] [Abstract][Full Text] [Related]
17. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
[TBL] [Abstract][Full Text] [Related]
18. Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
Martínez-Rodríguez JE; Cobo-Calvo A; Villar LM; Munteis E; Blanco Y; Rasal R; Vera A; Muntasell A; Alvarez-Lafuente R; Saiz A; Alvarez-Cermeño JC; Martínez-Yélamos S; Roquer J; López-Botet M
Mult Scler; 2016 May; 22(6):741-52. PubMed ID: 26362897
[TBL] [Abstract][Full Text] [Related]
19. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.
Rölle A; Pollmann J; Ewen EM; Le VT; Halenius A; Hengel H; Cerwenka A
J Clin Invest; 2014 Dec; 124(12):5305-16. PubMed ID: 25384219
[TBL] [Abstract][Full Text] [Related]
20. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
